Timing and risk factors for new brain metastasis formation in patients initially treated only with gamma knife surgery: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 3, 2011, Pages 763-768

  Sheehan, Jason P ^a   Yen, Chun Po ^a   Nguyen, James ^a   Rainey, Jessica A ^a   Dassoulas, Kasandra ^a   Schlesinger, David J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Gamma knife surgery; Karnofsky performance scale; Metastasis; Radiosurgery

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER RISK; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE COURSE; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; STEREOTACTIC RADIOSURGERY;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RADIOSURGERY; REGRESSION ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79952259104     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.2.JNS091539     Document Type: Article

References (32)

1. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665-1672, 2004 (Pubitemid 38670323)
2. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al: Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483-2491, 2006 (Pubitemid 43854963)
3. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al: Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68:1388-1395, 2007 (Pubitemid 47176822)
4. Atkins MB, Sosman JA, Agarwala S, Logan T, Clark JI, Ernstoff MS, et al: Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study. Cancer 113:2139-2145, 2008
5. Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL: Stereotactic radiosurgery for patients with "radioresistant" brain metastases. Neurosurgery 62 (Suppl 2):790-801, 2008
6. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al: Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037-1044, 2009
7. Ellerhorst J, Strom E, Nardone E, McCutcheon I: Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 49:93-97, 2001 (Pubitemid 32041280)
8. Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, et al: Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys 74:1543-1548, 2009
9. Jawahar A, Matthew RE, Minagar A, Shukla D, Zhang JH, Willis BK, et al: Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis. J Neurosurg 100:842-847, 2004 (Pubitemid 38533968)
10. Kihlström L, Karlsson B, Lindquist C: Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience. Stereotact Funct Neurosurg 61 (Suppl 1):45-50, 1993 (Pubitemid 24032056)
11. Kondziolka D, Martin JJ, Flickinger JC, Friedland DM, Brufsky AM, Baar J, et al: Long-term survivors after gamma knife radiosurgery for brain metastases. Cancer 104:2784-2791, 2005 (Pubitemid 41798289)
12. Lee DH, Han JY, Kim HT, Yoon SJ, Pyo HR, Cho KH, et al: Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first: result of a randomized pilot study. Cancer 113:143-149, 2008
13. Lee WY, Cho DY, Lee HC, Chuang HC, Chen CC, Liu JL, et al: Outcomes and cost-effectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors. J Clin Neurosci 16:630-634, 2009
14. Lutterbach J, Cyron D, Henne K, Ostertag CB: Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery 62 (Suppl 2):776-784, 2008
15. Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al: Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157-165, 2004 (Pubitemid 41095128)
16. Moscetti L, Nelli F, Felici A, Rinaldi M, De Santis S, D'Auria G, et al: Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology. Cancer 109:274-281, 2007 (Pubitemid 46106242)
17. Muacevic A, Kreth FW, Horstmann GA, Schmid-Elsaesser R, Wowra B, Steiger HJ, et al: Surgery and radiotherapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 91:35-43, 1999
18. Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, et al: Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 52:333-338, 2002 (Pubitemid 34172998)
19. Regine WF, Scott C, Murray K, Curran W: Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51:711-717, 2001
20. Rossi A, Maione P, Colantuoni G, Ferrara C, Rossi E, Guerriero C, et al: Recent developments of targeted therapies in the treatment of non-small cell lung cancer. Curr Drug Discov Technol 6:91-102, 2009
21. Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, et al: Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys 70:181-186, 2008 (Pubitemid 350251044)
22. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD: Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 97:1276-1281, 2002 (Pubitemid 35424280)
23. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, et al: Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549-558, 1999 (Pubitemid 29107174)
24. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, et al: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519-526, 2002 (Pubitemid 34626488)
25. Stevens G, Firth I, Coates A: Cerebral metastases from malignant melanoma. Radiother Oncol 23:185-191, 1992
26. Tiseo M, Bartolotti M, Gelsomino F, Ardizzoni A: First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype. Expert Rev Anticancer Ther 9:425-435, 2009
27. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N: Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 3:CD003869, 2006
28. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD: The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 62:1125-1132, 2005 (Pubitemid 40884427)
29. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD: Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 57:452-464, 2003 (Pubitemid 37040942)
30. Wen PY, Loeffler JS: Brain metastases. Curr Treat Options Oncol 1:447-458, 2000
31. Yen CP, Sheehan J, Patterson G, Steiner L: Gamma knife surgery for metastatic brainstem tumors. J Neurosurg 105:213-219, 2006
32. Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, et al: Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 52:1277-1287, 2002 (Pubitemid 34296488)